Cargando…
Correction to: High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer
Autores principales: | Xiao, Wenwu, Ma, Weijie, Wei, Sixi, Li, Qianping, Liu, Ruiwu, Carney, Randy P., Yang, Kevin, Lee, Joyce, Nyugen, Alan, Yoneda, Ken Y., Lam, Kit S., Li, Tianhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660960/ https://www.ncbi.nlm.nih.gov/pubmed/31349855 http://dx.doi.org/10.1186/s13045-019-0764-z |
Ejemplares similares
-
High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer
por: Xiao, Wenwu, et al.
Publicado: (2019) -
Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors
por: Xiao, Wenwu, et al.
Publicado: (2016) -
High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer
por: Li, Qianping, et al.
Publicado: (2020) -
Medical History from the Earliest Times: LXI.—The Organicists
por: Withington, E. T.
Publicado: (1893) -
Reports on the Hospitals of the United Kingdom: LXI. York County Hospital
por: Burdett, Henry
Publicado: (1912)